Horstick Georg, Lauterbach Michael, Kempf Tibor, Bhakdi Sucharit, Heimann Axel, Horstick Marina, Meyer Jürgen, Kempski Oliver
Second Medical Clinic, Johannes Gutenberg-University Mainz, Mainz, Germany.
Crit Care Med. 2002 Apr;30(4):851-5. doi: 10.1097/00003246-200204000-00023.
To evaluate the effects of an early, short-term albumin infusion on mesenteric microcirculation and global hemodynamics in hemorrhagic shock.
A prospective, randomized study.
Animal laboratory at a university medical clinic.
Seventeen Sprague-Dawley rats weighing 250-400 g.
The rats underwent median laparotomy and exteriorization of an ileal loop for intravital microscopy of the mesenteric microcirculation. Volume-controlled hemorrhagic shock was provoked by arterial blood withdrawal (2.5 mL/100 g body weight for 60 mins), followed by a 4-hr reperfusion period. Albumin (20%) or 0.9% NaCl was administered intravenously as a continuous infusion for 30 mins at the beginning of reperfusion. Reperfusion time mimicked a "prehospital" phase of 30 mins followed by a quasi "in-hospital" phase of 3.5 hrs. The "in-hospital" phase in both groups was initiated by substitution of blood followed by reperfusion with normal saline.
Central hemodynamics, mesenteric microcirculation, and arterial blood gas parameters were monitored before, during, and 60 mins after hemorrhagic shock, and for a 240-min follow-up period after initiation of reperfusion. Application of albumin markedly reduced rolling and adherent leukocytes, maximum velocity, and shear rate in the mesenteric microcirculation. Later, after improvement of mesenteric microcirculation, an intermittent increase of central venous pressure and abdominal blood flow and decrease of hematocrit was observed.
Albumin treatment of hemorrhagic shock improves microcirculation and global hemodynamics and attenuates the inflammatory response to reperfusion. It may provide clinical benefit when applied at an early stage of reperfusion during hemorrhagic shock.
评估早期短期输注白蛋白对失血性休克时肠系膜微循环和整体血流动力学的影响。
一项前瞻性随机研究。
大学医学诊所的动物实验室。
17只体重250 - 400克的Sprague-Dawley大鼠。
大鼠接受正中剖腹术并将一段回肠袢外置以进行肠系膜微循环的活体显微镜检查。通过抽取动脉血诱发容量控制性失血性休克(2.5毫升/100克体重,持续60分钟),随后进行4小时的再灌注期。在再灌注开始时,静脉持续输注20%白蛋白或0.9%氯化钠30分钟。再灌注时间模拟30分钟的“院前”阶段,随后是3.5小时的准“院内”阶段。两组的“院内”阶段均通过输血开始,随后用生理盐水进行再灌注。
在失血性休克前、休克期间、休克后60分钟以及再灌注开始后240分钟的随访期内,监测中心血流动力学、肠系膜微循环和动脉血气参数。输注白蛋白显著减少了肠系膜微循环中的滚动和黏附白细胞、最大速度和切变率。之后,在肠系膜微循环改善后,观察到中心静脉压和腹部血流量间歇性增加,血细胞比容降低。
白蛋白治疗失血性休克可改善微循环和整体血流动力学,并减轻对再灌注的炎症反应。在失血性休克再灌注早期应用可能具有临床益处。